结直肠癌的诊断与治疗新进展
New Progress in Diagnosis and Treatment of Colorectal Cancer
摘要: 结直肠癌(the colorectal cancer, CRC)是消化道常见的恶性肿瘤。近年来发病率依然较高，仍存在许多早期、中期患者被忽视或延误病情的情况。因此，对于CRC的二、三级预防尤为重要。包括对高危患者行粪便隐血试验OB、电子结肠镜、直肠指诊有利于疾病的早期发现，此外对于确诊为CRC的，应力争提高生存质量，延长寿命，降低病死率。目前，对于CRC的治疗方法包括内镜下切除，根治性手术切除，术前全身放化疗降低肿瘤分期的手术切除，转移灶的局部切除治疗以及姑息切除，全身放化疗、靶向和免疫治疗等。本文结合近年来国内外对CRC的诊断、治疗及预后方面的新研究进展展开综述。
Abstract: Colorectal cancer (CRC) is a common malignant tumor of the digestive tract. In recent years, the incidence rate is still high, and there are still many early and mid-stage patients who are neglected or delayed in their illness. Therefore, the secondary and tertiary prevention of CRC are particularly important. Including high-risk patients with stool occult blood test OB, electronic colonoscopy, and digital rectal examination are conducive to the early detection of the disease. In addition, for those diagnosed with CRC, we should strive to improve the quality of life, prolong life, and reduce the mortality rate. At present, the treatment methods for CRC include endoscopic resection, radical surgical resection, preoperative systemic radiotherapy and chemotherapy to reduce tumor stage surgical resection, local resection and palliative resection of metastases, systemic radiotherapy and chemotherapy, targeted therapy and immunotherapy Wait. This article summarizes the new research progress in the diagnosis, treatment and prognosis of CRC at home and abroad in recent years.
文章引用：周海军, 白铁成, 刘涛, 曹波, 李恺鹏. 结直肠癌的诊断与治疗新进展[J]. 临床医学进展, 2021, 11(4): 1747-1754. https://doi.org/10.12677/ACM.2021.114251

参考文献

[1] Dekker, E., Tanis, P.J., Vleugels, J., et al. (2019) Colorectal Cancer. The Lancet, 394, 1467-1480. [Google Scholar] [CrossRef] 
[2] 李为民, 刘丹, 卢铀. 肺癌诊治水平的进展与提高[J]. 四川大学学报(医学版), 2014, 45(2): 289-292.
[3] 朱成章, 张维胜, 杜斌斌, 等. 肠道菌群失调与罹患结直肠癌风险的研究进展[J]. 中华结直肠疾病电子杂志, 2021, 10(1): 95-98.
[4] 卫生部医政司, 卫生部办公厅. 结直肠癌诊疗规范(2010年版) [J]. 中华外科杂志, 2011(2): 97-104.
[5] 屠世良, 叶再元, 邓高里, 等. 结直肠癌淋巴结转移的规律及其影响因素[J]. 中华胃肠外科杂志, 2007(3): 257-260.
[6] 李季, 沈艳, 姜研. CT仿真结肠镜联合肿瘤标志物检测在结直肠癌中的诊断价值[J]. 医学综述, 2021, 27(5): 1032-1036.
[7] 游金辉, 黄霓. 结直肠癌PET/CT显像的应用与研究进展[J]. 川北医学院学报, 2019, 34(1): 155-159.
[8] 豆晓锋, 邵佳栋, 李晶. PET/CT显像在结直肠癌术后复发及转移诊断中的临床应用价值[J]. 影像研究与医学应用, 2018, 2(22): 6-7.
[9] 李宣海. 肿瘤标志物的检测与临床[M]. 北京: 人民卫生出版社, 1997.
[10] 崔秀玉, 李秀平, 于谨铭, 等. 血清CA199, CA242, CEA联合检测对胰腺癌的临床意义[J]. 医学检验与临床, 2010, 21(5): 14-15, 13.
[11] 孙巍, 王琼, 刘娟, 等. 血清肿瘤标志在结直肠癌诊断中的应用[J]. 中华检验医学杂志, 2000(1): 10-12.
[12] 边鹏, 刘瑞红, 张喜雨, 等. 基于病案数据的结直肠癌远处转移影响因素分析[J]. 中国病案, 2021, 22(3): 86-90.
[13] 史益凡, 林春燕, 鲍传庆, 等. 中西医结合快速康复外科理念在腹腔镜结直肠癌手术中的应用[J]. 中国中西医结合外科杂志, 2018, 24(6): 766-769.
[14] 练磊, 兰平. 国家卫健委中国结直肠癌诊疗规范解读(2020版)——外科部分[J]. 临床外科杂志, 2021, 29(1): 10-12.
[15] Andreola, S., Leo, E., Belli, F., et al. (1997) Distal Intramural Spread in Adenocarcinoma of the Lower Third of the Rectum Treated with Total Resection and Coloanal Anastomosis. Diseases of the Colon & Rectum, 40, 25-29. [Google Scholar] [CrossRef] 
[16] Wolmark, N. and Fisher, B. (1986) An Analysis of Survival and Treatment Failure Following Abdominoperineal and Sphincter-Saving Resection in Dukes’ B and C Rectal Carcinoma. A Report of the NSABP Clinical Trials. National Surgical Adjuvant Breast and Bowel Project. Annals of Surgery, 204, 480-489. [Google Scholar] [CrossRef] [PubMed]
[17] Kim, Y., Kim, N., Min, B., et al. (2009) Factors Associated with Anastomotic Recurrence after Total Mesorectal Excision in Rectal Cancer Patients. Journal of Surgical Oncology, 99, 58-64. [Google Scholar] [CrossRef] [PubMed]
[18] 封益飞, 唐俊伟, 王勇, 等. 肠道支架置入联合择期手术与急诊手术在梗阻性结直肠癌治疗中的对比分析[J]. 腹腔镜外科杂志, 2021, 26(3): 218-222.
[19] Borschitz, T., Wachtlin, D., Hler, M., et al. (2008) Neoadjuvant Chemoradiation and Local Excision for T2-3 Rectal Cancer. Annals of Surgical Oncology, 15, 712-720. [Google Scholar] [CrossRef] [PubMed]
[20] Read, T.E., Andujar, J.E., Caushaj, P.F., et al. (2004) Neoadjuvant Therapy for Rectal Cancer: Histologic Response of the Primary Tumor Predicts Nodal Status. Diseases of the Colon & Rectum, 47, 825-831. [Google Scholar] [CrossRef] [PubMed]
[21] Petrelli, F., Trevisan, F., Cabiddu, M., et al. (2019) Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-Analysis of Treatment Outcomes. Annals of Surgery, 271, 1. [Google Scholar] [CrossRef] 
[22] 肖刘牛, 朱丽, 陈颖铭, 等. II期结直肠癌术后化疗临床预后危险因素的Meta分析[J]. 循证医学, 2019, 19(3): 167-177.
[23] 樊嘉, 顾晋, 秦新裕, 等. 中国结直肠癌肝转移诊断和综合治疗指南(2020) [J]. 中国临床医学, 2021, 28(1): 129-144.
[24] Andre, T., Boni, C., Navarro, M., et al. (2009) Improved Overall Survival with Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial. Journal of Clinical Oncology, 27, 3109-3116. [Google Scholar] [CrossRef] 
[25] Tveit, K.M., et al. (1997) Combined Modality Treatment Including Intraoperative Radiotherapy in Locally Advanced and Recurrent Rectal Cancer. Radiotherapy and Oncology, 44, 277-282. [Google Scholar] [CrossRef] 
[26] Yu, T.K., Bhosale, P.R., Crane, C.H., et al. (2008) Patterns of Locoregional Recurrence after Surgery and Radiotherapy or Chemoradiation for Rectal Cancer. International Journal of Radiation Oncology Biology Physics, 71, 1175-1180. [Google Scholar] [CrossRef] [PubMed]
[27] Stillwell, A.P., Buettner, P.G. and Ho, Y.H. (2010) Meta-Analysis of Survival of Patients with Stage IV Colorectal Cancer Managed with Surgical Resection versus Chemotherapy Alone. World Journal of Surgery, 34, 797-807. [Google Scholar] [CrossRef] [PubMed]
[28] van Rooijen, K.L., Shi, Q., Goey, K., et al. (2018) Prognostic Value of Primary Tumour Resection in Synchronous Metastatic Colorectal Cancer: Individual Patient Data Analysis of First-Line Randomised Trials from the ARCAD Database. European Journal of Cancer, 91, 99-106. [Google Scholar] [CrossRef] [PubMed]
[29] 王磊, 蔡建, 秦启元. 结直肠癌腹膜转移治疗的争议与思考[J]. 中华外科杂志, 2018, 56(8): 569-572.
[30] 崔书中, 王佳泓, 张相良. 肿瘤细胞减灭术联合腹腔热灌注化疗治疗结直肠癌腹膜转移癌[J]. 中国肿瘤临床, 2012, 39(22): 1691-1695.
[31] Park, E.J., Baik, S.H., Hur, H., et al. (2017) Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Cancer with Peritoneal Carcinomatosis. Medicine, 96, e6632. [Google Scholar] [CrossRef] 
[32] Portilla, A.G., Cendoya, I., Tejada, I., et al. (2005) Peritoneal Carcinomatosis of Colorectal Origin. Current Treatment. Review and Update. Revista Espanola de Enfermedades Digestivas, 97, 716. [Google Scholar] [CrossRef] 
[33] 赵志勋, 裴炜, 熊斌, 等. 结直肠癌腹膜转移诊治中国专家意见(2017) [J]. 中华结直肠疾病电子杂志, 2017, 6(5): 360-366.
[34] Roemer-Becuwe, C., Krakowski, I. and Conroy, T. (2003) Bisphosphonates, Pain and Quality of Life in Metastatic Breast Cancer Patients: A Literature Review. Bulletin du Cancer, 90, 1097-1105.
[35] 马晨曦, 关旭, 王锡山. 结直肠癌骨转移的研究现状及治疗[J]. 中华结直肠疾病电子杂志, 2020, 9(6): 605-609.
[36] 赵亮, 苏佳灿. 结直肠癌骨转移研究进展[J]. 中国骨与关节杂志, 2012, 1(2): 182-184.
[37] Sorich, M.J., Wiese, M.D., Rowland, A., et al. (2015) Extended RAS Mutations and Anti-EGFR Monoclonal Antibody Survival Benefit in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized, Controlled Trials. Annals of Oncology Official Journal of the European Society for Medical Oncology, 26, 13-21. [Google Scholar] [CrossRef] [PubMed]
[38] 高静, 孙志伟, 李艳艳, 等. 中国结直肠癌患者966例中KRAS和BRAF基因突变分析[J]. 中华病理学杂志, 2012(9): 579-583.
[39] 陈海霞, 何亚楠, 王维娜, 等. 结直肠癌组织中KRAS和BRAF基因突变与临床病理特征及预后的关系[J]. 现代肿瘤医学, 2021, 29(4): 626-631.
[40] 潘思琼, 陆奉科, 李山. 错配修复蛋白MLH1、MSH2、PMS2、MSH6及p53在结直肠癌中的表达及意义[J]. 海南医学, 2021, 32(1): 4-7.
[41] 黎相照, 刘焕娇, 梁敏仪, 等. 微卫星不稳定性类型及临床病理特征: 基于1394例结直肠癌患者的标本检测[J]. 南方医科大学学报, 2020, 40(11): 1645-1650.
[42] 刘荫华, 姚宏伟, 周斌, 等. 美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J]. 中国实用外科杂志, 2017(1): 6-9.
[43] 韩慧敏, 王鹏, 朱冰, 等. 脉管瘤栓在II期结直肠癌中的临床价值研究[J]. 实用肿瘤杂志, 2021, 36(1): 43-46.
[44] Kishiki, T., Lapin, B., Matsuoka, H., et al. (2018) Optimal Surveillance Protocols after Curative Resection in Patients with Stage IV Colorectal Cancer: A Multicenter Retrospective Study. Diseases of the Colon & Rectum, 61, 51-57. [Google Scholar] [CrossRef] 
[45] 钟玲, 郅程. 阳性淋巴结对数比对Ⅲ期结直肠癌预后的预测价值[J]. 消化肿瘤杂志(电子版), 2020, 12(4): 256-260.

为你推荐